Additional research confirmed that melanoma EVs isolated from the plasma of these patients consistently carry FasL and TRAIL, with FasL-blocking antibodies partially reducing the apoptosis of T cells induced by these EVs in vitro [90]. This evidence concerns the gene FASLG and melanoma.